Back
The Carlyle Group Inc. Vs. Zenas BioPharma, Inc. Industry Stock Comparison
Buy
80
CG
The Carlyle Group Inc.
Last Price:
$60.89
Seasonality Move:
0.65%
Buy
60
ZBIO
Zenas BioPharma, Inc.
Last Price:
$42.83
Seasonality Move:
0.59%
Buy
80
The Carlyle Group Inc. (CG)
is a Buy
Is The Carlyle Group Inc. a Buy, Sell or Hold?
-
The current The Carlyle Group Inc. [CG] share price is $60.92. The Score for CG is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
-
CG is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
60
Zenas BioPharma, Inc. (ZBIO)
is a Buy
Is Zenas BioPharma, Inc. a Buy, Sell or Hold?
-
The current Zenas BioPharma, Inc. [ZBIO] share price is $42.81. The Score for ZBIO is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
-
ZBIO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CG Stock Price Chart
What is The Carlyle Group Inc.'s stock price today?
-
The The Carlyle Group Inc. share price today is $60.92Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CG is experiencing selling pressure, which indicates risk of future bearish movement.
ZBIO Stock Price Chart
What is Zenas BioPharma, Inc.'s stock price today?
-
The Zenas BioPharma, Inc. share price today is $42.81Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ZBIO is experiencing buying pressure, which is a positive indicator for future bullish movement.
CG Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.45 | Buy |
| Relative Strength Index (14 RSI): | 65.26 | Buy |
| Chaikin Money Flow: | -2129391 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (52.93 - 59.29) | Buy |
| Bollinger Bands (100): | (54.9 - 64.64) | Buy |
ZBIO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 9.79 | Buy |
| Relative Strength Index (14 RSI): | 61.76 | Buy |
| Chaikin Money Flow: | 156273 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (35.4 - 40.3) | Buy |
| Bollinger Bands (100): | (17.9 - 35) | Buy |
CG Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 59.12 | Buy |
| 20-day SMA: | 57.23 | Buy |
| 50-day SMA: | 55.79 | Buy |
| 200-day SMA: | 53.29 | Buy |
| 8-day EMA: | 59.5 | Buy |
| 20-day EMA: | 57.76 | Buy |
| 50-day EMA: | 57.16 | Buy |
| 200-day EMA: | 54.98 | Buy |
ZBIO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 37.78 | Buy |
| 20-day SMA: | 38.2 | Buy |
| 50-day SMA: | 33.84 | Buy |
| 200-day SMA: | 18.39 | Buy |
| 8-day EMA: | 28.27 | Buy |
| 20-day EMA: | 15.3 | Buy |
| 50-day EMA: | 7 | Buy |
| 200-day EMA: | 1.88 | Buy |
The Carlyle Group Inc. Earnings Growth & CG Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.36 per share, and an increase next year of $0.74 per share.
Zenas BioPharma, Inc. Earnings Growth & ZBIO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.65 per share, and an increase next year of $0.59 per share.
The Carlyle Group Inc. Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Zenas BioPharma, Inc. Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||